JPS61177993A - Production of l-isoleucine - Google Patents

Production of l-isoleucine

Info

Publication number
JPS61177993A
JPS61177993A JP1750185A JP1750185A JPS61177993A JP S61177993 A JPS61177993 A JP S61177993A JP 1750185 A JP1750185 A JP 1750185A JP 1750185 A JP1750185 A JP 1750185A JP S61177993 A JPS61177993 A JP S61177993A
Authority
JP
Japan
Prior art keywords
isoleucine
aminobutyric acid
ethanol
culture
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1750185A
Other languages
Japanese (ja)
Inventor
Masato Terasawa
真人 寺沢
Shoichi Nara
昭一 奈良
Hideaki Yugawa
英明 湯川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Petrochemical Co Ltd
Original Assignee
Mitsubishi Petrochemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Petrochemical Co Ltd filed Critical Mitsubishi Petrochemical Co Ltd
Priority to JP1750185A priority Critical patent/JPS61177993A/en
Publication of JPS61177993A publication Critical patent/JPS61177993A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PURPOSE:To produce efficiently L-isoleucine, by cultivating a microorganism of the genus Brevibacterium having a special activity aerobically in a culture medium containing ethanol as a main carbon source and DL-alpha-aminobutyric acid, etc. CONSTITUTION:A culture medium is prepared by incorporating 1-5vol% ethanol with 0.1-5wt% DL-alpha-aminobutyric acid or D-alpha-aminobutyric acid, ammonia, etc., as a nitrogen source, KH2PO4, etc., as an inorganic salt and other peptone, vitamin, etc. A precultivated Brevibacterium flavum which is an ethanol assimilating microorganism having enhanced D-alpha-aminobutyric acid deaminase activity is inoculated into the above-mentioned culture medium, and cultivated at 20-40 deg.C and 5-10pH under aerobic conditions of spinner culture or shaking culture with aeration for 2-9 days to produce and accumulate the aimed L- isoleucine in the culture fluid. The microbial cells, etc., are removed by centrifugation to collect L-isoleucine by the ion exchange resin treatment method, etc.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は発酵法によるL−イソロイシンの製存せしめ、
ブレビバクテリウム属に属しD−α−アミノ酪酸デアミ
ナーゼ活性の増大したエタノール資化性微生物を好気的
に培養し、その培養液中のL−イソロイシンを採取する
ことを特徴とするL′−イソロイシンの製造法である。
Detailed Description of the Invention (Industrial Application Field) The present invention is directed to the production of L-isoleucine by a fermentation method,
L'-isoleucine, which is characterized in that an ethanol-assimilating microorganism belonging to the genus Brevibacterium and having increased D-α-aminobutyric acid deaminase activity is cultivated aerobically, and L-isoleucine in the culture solution is collected. This is the manufacturing method.

(従来技術と課題) L−イソロイシンは必須アミノ酸として、人間および動
物の栄養上M要な役割をするアミノ酸であり、医療、食
品、飼料強化剤としてその?J要が近年急減に増加しつ
つある。L−イソロイシンの工業的製造法としては、他
のアミノ酸の場合と同様に立体異性坏が存在する為、化
学合成法ではL体のみの製造は困難であり、主に発酵法
により生産が行なわれている。発酵法としてFiDL−
α−アミノ酪ば、スレオニン等のイア5T!II直接発
酵法(特公昭38−7091. %hJ昭49−935
86等)がある。
(Prior art and issues) L-isoleucine is an essential amino acid that plays an important role in the nutrition of humans and animals, and is used as a medical, food, and feed fortifier. The number of J-types has been rapidly decreasing in recent years. As for the industrial production method of L-isoleucine, it is difficult to produce only the L-isomer by chemical synthesis method because stereoisomerism exists as in the case of other amino acids, and production is mainly carried out by fermentation method. ing. FiDL- as a fermentation method
Ia 5T such as α-amino butybean and threonine! II Direct Fermentation Method (Special Publication No. 38-7091. %hJ 1977-935
86 etc.).

その中でα−アミノvI11rRを前駆坏とするL−イ
ソロイシンの製造法〒は、α−アミノ酪ばは化学合成法
によりDL体が最も容易に、安価に製造されることから
前駆体としてはDL−α−アミノ酪酸を用いるのが好ま
しい。
Among them, the method for producing L-isoleucine using α-amino vI11rR as a precursor is based on the fact that the DL form of α-amino butylene is most easily and inexpensively produced by chemical synthesis. -α-aminobutyric acid is preferably used.

本発明者らはすでにブレビバクテリウム・フラバムに属
するエタノール資化性微生物MJ−233(FERM−
P4O10)を用いてDL−α−アミノ酪酸を培地に添
加してL−イソロイシンを製造する方法を提案している
(特公昭57−26755)。
The present inventors have already reported that the ethanol-utilizing microorganism MJ-233 (FERM-
proposed a method for producing L-isoleucine by adding DL-α-aminobutyric acid to a medium using P4O10 (Japanese Patent Publication No. 57-26755).

上記のMJ−233を用いたL−イソロイシンの生産に
おいては、L体のアミノ酪ばはすみやかに消費され、L
−イソロイシンの蓄積が認められるが、一方り坏のアミ
ノ酪酸からのL−イソロイシンの生産速度は非常に低い
ことが判明した。従って1)L−α−アミノ酪酸を前駆
体として用いる場合には、D−α−アミノ酪酸からのL
−イソロイシンの生成速度を増大させることにより、全
停としてさらに効率的にL−イソロイシンを製造するこ
とが期待される。
In the production of L-isoleucine using MJ-233 mentioned above, the L-aminobutybean is quickly consumed, and the L-isoleucine is quickly consumed.
- Although accumulation of isoleucine was observed, the production rate of L-isoleucine from aminobutyric acid was found to be very low. Therefore, 1) When using L-α-aminobutyric acid as a precursor, L from D-α-aminobutyric acid
- By increasing the production rate of isoleucine, it is expected that L-isoleucine can be produced more efficiently as a complete stop.

(構成及び効果) ここにおいて本発明者らは、D−α〒アミン酪酸からの
インロイシン生成速度の向上を目標として鋭意研究を進
めたところ、D−α−アミノ酪酸デアミナーゼ活性を増
大させることによシ、D−α−アミノ酪酸も比較的すみ
やかに利用されてL−イソロイシンの蓄積が認められ、
結果的にOL−α−アミノ酪kを用いた場合にも生成速
度が向上することが判明し本発明に到達するに至った。
(Structure and Effect) Here, the present inventors conducted intensive research with the aim of improving the rate of inleucine production from D-α-aminobutyric acid, and found that increasing D-α-aminobutyric acid deaminase activity Additionally, D-α-aminobutyric acid was also utilized relatively quickly, leading to accumulation of L-isoleucine.
As a result, it was found that the production rate was also improved when OL-α-aminobutyric k was used, leading to the present invention.

このことfl、DL−α−アミノ酪酸のL体を他用途に
使用した場合に残存するD−α−アミノ酪酸を有効に利
用することにも応用可能である。
This can also be applied to effectively utilizing the D-α-aminobutyric acid remaining when the L form of fl and DL-α-aminobutyric acid is used for other purposes.

本発明の要旨は「ブレビバクテリウム属に属し、D−α
−アミノ酪ばデアミナーゼ活性が増大したエタノール資
化性微生物を、エタノールを主炭素源とし且DL−α−
アミノ酪酸もしくはD−α−アミノ酪rRを含む培地に
、好気的に培養して培養液中にL−イソロイシンを生産
蓄積せしめ、この培養液よりL−イソロイシンを採取す
ることを特徴とする発酵法によるL−イソロイシンの製
造法」である。以下本明細簀中において形容詞として用
いられている「l)−α−アミノ酪酸デアミナーゼ高活
江」なる修飾語は上記の不発明の賛旨申のrL)−α−
アミノ酪酸デアミナーゼ活性が増大した」という修飾語
と同じ意味をもつものである。
The gist of the present invention is that “D-α belongs to the genus Brevibacterium.
- Ethanol-assimilating microorganisms with increased aminobutyrate deaminase activity that use ethanol as the main carbon source and DL-α-
Fermentation characterized by culturing aerobically in a medium containing aminobutyric acid or D-α-aminobutyric rR to produce and accumulate L-isoleucine in the culture solution, and collecting L-isoleucine from this culture solution. ``Production method of L-isoleucine by method''. The modifier "l)-α-aminobutyric acid deaminase high activity" used as an adjective in the present specification is hereinafter referred to as rL)-α-
It has the same meaning as the modifier "aminobutyric acid deaminase activity increased."

本発明において使用するD−α−アミノ酪はデアミナー
ゼ高活性変異株は、例えば次の操作によって得られる。
The D-α-aminobutyric deaminase-high activity mutant used in the present invention can be obtained, for example, by the following procedure.

紫外線照射、あるいは化学的薬剤(例えばN−メチル−
N’−二トローN−二トロソクアニジン等)処理により
、ブレビバクテリウム・フラバムMJ −233(FF
ERM−P4O10)に変異を誘起せしめた後、この菌
懸濁液を平板培地(尿素0.2%、硫安0.7チ、 K
HxP040.05チ、に叩0゜0.0541Mg5O
n ・7Hs00.05%、NaCA! 2yq/73
゜ZnSO4・7H202岬/l、ビオチア 200 
pf/l、チアミン塩酸塩100.uf/l、l)−α
−アミノ酪酸0.2チ  を基本培地とし、これに寒天
2.0%、エタノール3容煮チを添加したもの) [、
約30℃にて数日間培養し生じた大コロニーを分離した
のち、各コロニーを上記基本培地10ゴを含む24φ犬
型試験管に殖菌し、エタノール2谷量チを姉加後30℃
で48時間振とう培養を行う。
UV irradiation, or chemical agents (e.g. N-methyl-
Brevibacterium flavum MJ-233 (FF
After inducing mutations in ERM-P4O10), this bacterial suspension was placed in a plate culture medium (urea 0.2%, ammonium sulfate 0.7%, K
HxP040.05chi, 0゜0.0541Mg5O
n ・7Hs00.05%, NaCA! 2yq/73
゜ZnSO4・7H202 Cape/l, Biotia 200
pf/l, thiamine hydrochloride 100. uf/l,l)-α
- 0.2% aminobutyric acid as the basic medium, to which 2.0% agar and 3 volumes of ethanol were added) [,
After culturing at approximately 30°C for several days and separating the resulting large colonies, each colony was inoculated into a 24φ dog-shaped test tube containing 10 volumes of the above basic medium, and after adding 2 volumes of ethanol, the cells were incubated at 30°C.
Culture with shaking for 48 hours.

該培養物を遠心分離により集画した後、100mMリン
酸カリウム緩衝液(pH7,0)にて2回洗浄後、D−
α−アミノ酪嘔デアミナーゼ活性測定用反応液(D−α
−アミノ酪酸25μmoles+リン酸カリウム緩衝液
(pH7,5)  100 pmoles。
The culture was collected by centrifugation, washed twice with 100mM potassium phosphate buffer (pH 7.0), and then D-
Reaction solution for measuring α-aminobutyrodeaminase activity (D-α
- 25 μmoles of aminobutyric acid + 100 pmoles of potassium phosphate buffer (pH 7,5).

ピリドキサール5すy g O,025pmoles、
  )リドンX−100,1重量%、脱イオン水1−)
の1d中に懸濁して、30℃にて18時間振盪反応を行
う。反応終了後、遠心分離(400Orpm。
Pyridoxal 5syg O,025pmoles,
) Ridone X-100, 1% by weight, deionized water 1-)
1d, and a shaking reaction is carried out at 30°C for 18 hours. After the reaction is completed, centrifugation (400 rpm).

15分間)にて菌体を除去した上澄液中のD−α−アミ
ノ酪酸の濃度を測定し、単位時間、単位菌体当シのD−
α−アミノ酪酸の減少量をもってD−α−アミノ酪酸デ
アミナーゼ化活性とする。本発明においてD−α−アミ
ノ酪酸デアミナーゼ高活性株(微生物)とは、そのD−
α−アミノ酪ばデアミナーゼ比活性が、ブレビバクテリ
ウム・フラバムMJ−233の比活性に比較し30%以
上増大した変異株を意味する。上記の操作によって取得
した代表的な友異体としては、ブレビバクテリウム豊フ
ラバムMJ−233−ABD−21(以下略してmJ−
233−ABD−21と記す)がめる。この菌株は工業
技術院微生物工業技術研究所に受託番号微工研菌寄第8
055号(昭和60年1月21日)として受託されてい
る。この変異株はブレビバクテリウム拳フラバム1旧−
233(FERM−P 3068)よりD−α−アミノ
酪醒デアミナーゼ高活性株として誘導されたものである
。このMJ−233−ABD−21のD−α−アミノ酪
酸デアミナーゼ比活性は、その親株であるMJ −23
3の比活性に比較し35%増大している。
The concentration of D-α-aminobutyric acid in the supernatant after removing the bacterial cells was measured, and the D-
The amount of decrease in α-aminobutyric acid is defined as D-α-aminobutyric acid deaminase activity. In the present invention, the D-α-aminobutyric acid deaminase highly active strain (microorganism) refers to the D-
It means a mutant strain in which α-aminobutyric deaminase specific activity is increased by 30% or more compared to the specific activity of Brevibacterium flavum MJ-233. A typical allogene obtained by the above procedure is Brevibacterium aeroflavum MJ-233-ABD-21 (hereinafter abbreviated as mJ-
233-ABD-21). This strain was submitted to the Institute of Microbial Technology, Agency of Industrial Science and Technology, with accession number No. 8.
It has been entrusted as No. 055 (January 21, 1985). This mutant strain is Brevibacterium kistoflavum 1 old-
233 (FERM-P 3068) as a strain with high D-α-aminobutyric deaminase activity. The D-α-aminobutyric acid deaminase specific activity of MJ-233-ABD-21 is different from that of its parent strain MJ-23.
The specific activity is increased by 35% compared to No. 3.

以下に本発明のL−イソロイシンの製造法を具体的に説
明する。
The method for producing L-isoleucine of the present invention will be specifically explained below.

本発明の培養に使用する培地組成は、エタノールを主炭
素源とし、且DL−α−アミノ酪酸あるいはD−α−ア
ミノ酪M、を含有するものであれば、窒素源無機塩tl
′ithに限定されない。窒素源としてはアンモニヤ、
硫酸アンモニウム、塩化アンモニウム、硝酸アンモニウ
ム、尿素等を単独もしくは混合して用いることが出来る
The medium composition used for the culture of the present invention is such that it uses ethanol as the main carbon source and contains DL-α-aminobutyric acid or D-α-aminobutyric acid, nitrogen source inorganic salt tl
'ith. Ammonia as a nitrogen source,
Ammonium sulfate, ammonium chloride, ammonium nitrate, urea, etc. can be used alone or in combination.

無機塩としては、リン酸−氷菓カリウム、リンば二水素
カリウム、硫酸マグネシウム等が用いられる。この他に
菌の生育及びL−イソロイシン生成に必要であれば、ペ
プトン、肉エキス、酵母エキス、コーンステイープリカ
ー、カザミノば、各裡ビタミン等の栄養素を培地に添加
し用いる。
As the inorganic salt, phosphoric acid-frozen potassium, phosphoric acid potassium dihydrogen, magnesium sulfate, etc. are used. In addition, nutrients such as peptone, meat extract, yeast extract, cornstarch liquor, Casaminoba, and various vitamins may be added to the medium if necessary for bacterial growth and L-isoleucine production.

培養は通気攪拌、振盪等の好気的条件下で行ない、培養
温度は20〜40℃好ましくtli25〜35℃で行な
う。培養途中のpHは5〜10好ましくは7〜8付近に
て行ない、培養中のpHの調整には酸、アルカリを添加
して行なう。
The culture is carried out under aerobic conditions such as aeration and shaking, and the culture temperature is preferably 20 to 40°C, preferably tli 25 to 35°C. The pH during the cultivation is maintained at around 5-10, preferably around 7-8, and the pH during the cultivation is adjusted by adding acid or alkali.

OL−α−アミノ酪酸又FiD−α−アミノ酪改の添加
製置は、0.1〜5重1tチ好ましくは、0.25〜3
重′1ttsである。培養開始時のエタノール良度は1
〜5答量チ、好ましくは2〜3谷策チが適する。培養期
間tr12〜9日間、最適期間は4〜7日間である。培
養液からのL−イソロイシンの回収に、培Vk液を遠心
分離等にかけてm坏吟の除坤後、公知の手法、すなわち
イオン父瀕樹脂処理法めるいは、沈減法等により容易に
行なうことが出来る。、以下に実施?lJを示す。
The addition and preparation of OL-α-aminobutyric acid or FiD-α-aminobutyric acid is 0.1 to 5 parts per ton, preferably 0.25 to 3
It is heavy '1tts. Ethanol quality at the start of culture is 1
~5 answers, preferably 2 to 3 answers. The culture period tr is 12 to 9 days, and the optimal period is 4 to 7 days. To recover L-isoleucine from the culture solution, the culture Vk solution is centrifuged, etc. to remove the m-condensation, and then it can be easily carried out by known methods, i.e., the ionizing resin treatment method, the sedimentation method, etc. I can do it. , carried out below? Indicates lJ.

なお、L−イソロイシンの足性に、ベーハークロマトグ
ラフのRf値、電気泳動性の易動雇、値生物定を伝によ
る生物活性旭により確認した。
In addition, the properties of L-isoleucine, the Rf value of Beher chromatography, the mobility of electrophoresis, and the value of bioactivity were confirmed by bioactivity assay according to Dentsu.

定ttaロイコノストック・メセンテロイデスATCC
8042を用いるマイクロバイオアッセイ法と烏速液俸
グロマトグラフイー11津り、C−5A)とを併用して
行なった。また下記の実施汐りにおいてチと表わしたの
は′N童チを意味する。
Leuconostoc mesenteroides ATCC
The microbioassay method using 8042 was carried out in combination with Cosmos chromatography (C-5A). In addition, in the following implementation, ``chi'' means ``Ndochi''.

実7m?lJ1 前培養培地(尿素0.4 %、硫ばアンモニウム1.4
%、KH2PO40,05% 、 K2HPO40,0
5%、MgSO4・7H200,05%、CaCA’ 
@ 2’fis02 ppm。
Actual 7m? lJ1 preculture medium (urea 0.4%, ammonium sulfate 1.4%)
%, KH2PO40.05%, K2HPO40.0
5%, MgSO4.7H200.05%, CaCA'
@2'fis02 ppm.

Fe50+ ” 7H202ppm %Mn5O< ’
 4〜6 H2O2pPm %Znb(Ja ” 7 
H2O2ppm %NaCl2 ppm−ビオチン20
0μy/l、チアミン・HCl100μす、カザミノI
N o、 1%、酵母エキス0.1%)1〇−を24φ
大型試験管に分圧、滅菌(滅菌後pf(7,0)した後
MJ−233−ABLE−21(微工研菌薔第8055
号)を植菌し、無菌的にエタノールを0.3−加え、3
0℃にて2日間振盪培重を行なった。
Fe50+ "7H202ppm %Mn5O<'
4-6 H2O2pPm%Znb(Ja” 7
H2O2ppm %NaCl2 ppm-Biotin 20
0μy/l, thiamine/HCl 100μs, Casamino I
No, 1%, yeast extract 0.1%) 1〇-24φ
After applying partial pressure to a large test tube and sterilizing it (pf (7,0) after sterilization),
No.), add 0.3 - ethanol aseptically, and
The culture was incubated with shaking at 0°C for 2 days.

次に本培養培地(尿X0.4%、硫叡アンモニウム1.
4%、K2HO40,05%、K2HPO40,05%
、MgSO4@ 7)ho O,05%、CaC1z 
@ 2 H2O2ppm。
Next, the main culture medium (urine X 0.4%, ammonium sulfate 1.
4%, K2HO40.05%, K2HPO40.05%
, MgSO4@7)ho O,05%, CaC1z
@2H2O2ppm.

Fe5Oi @ 7 fbo 2 ppm s Mn5
O+ ・4〜6H202ppm%ZnSO4* 7 )
ho 2 ppm% NtaCl 2 ppm。
Fe5Oi @ 7 fbo 2 ppm s Mn5
O+ ・4~6H202ppm%ZnSO4*7)
ho2ppm% NtaCl2ppm.

ビオチン200μt/l 、チアミン・H(J100μ
t/l 、 コーンステイープリカー10ゴ/l。
Biotin 200μt/l, Thiamine H (J100μt/l)
t/l, corn staple liquor 10 go/l.

DL−α−アミノ酪酸0.5チ)10−を、24φ大型
試験管に分注、滅菌後(滅菌後pH7,0)、前培養液
を0.1−植菌し、無菌的にエタノールを0.3−加え
、30℃にて7日間重量培養を行なう。エタノールは消
費にともない添加する。
DL-α-aminobutyric acid (0.5%) was dispensed into a 24φ large test tube, and after sterilization (pH 7.0 after sterilization), 0.1% of the preculture solution was inoculated, and ethanol was added aseptically. 0.3- and carry out weight culture at 30°C for 7 days. Ethanol is added as it is consumed.

(この時エタノールは3容tSを越えないようにする。(At this time, the ethanol should not exceed 3 volumes tS.

また全エタノール消責11Fi6.5答J1チでめった
。)培養7日月KL−イソロイ/ンが培養液1g当り4
,32蓄槓された。
Also, I lost all ethanol in 11 Fi 6.5 answers J1 Chi. ) Cultured for 7 days
, 32 were accumulated.

培!液から醒坏その他不純物を除いた濾液を、強醒性陽
イオン交換m脂(H1型)のカラムに通して、L−イソ
ロイシンを吸着させ、水洗後、0.5Nアンモニア水で
溶出したのち、L−イソロイシン画分を@庵し、冷エタ
ノールでL−イソロイシンの結晶を析出させ、培養液1
1当92.5Fの粗結晶を得た。
Cultivate! The filtrate, which has been removed from the liquid by removing sulfuric acid and other impurities, is passed through a column of strong cation exchange m fat (H1 type) to adsorb L-isoleucine, washed with water, and eluted with 0.5N aqueous ammonia. The L-isoleucine fraction was separated, L-isoleucine crystals were precipitated with cold ethanol, and culture solution 1
Crude crystals of 92.5F per portion were obtained.

なお、同条件で親株(ivfJ−233)を使用した場
合、培地中のL−イソロイシンの蓄、槓ハ培養o、11
当す3.59テhツfc。
In addition, when using the parent strain (ivfJ-233) under the same conditions, the accumulation of L-isoleucine in the medium,
That's 3.59 tfc.

実施例12 実m汐+41と同様の条件で前培養を行った。次に本培
養培地(尿素0.4%、硫酸アンモニウム−1,4%、
K2HPO40,05%、K2HPO40,05チ、M
g S04 ・7 HxO0,05To、CaC1z 
# 2 Hzo 2 PPm%FeSO4・7H202
ppmSMn5O+ ・4〜6 HsO2ppm%Zn
SO4” 71(202ppm、 N&C12ppm、
ビオチン200μfl/l、チアミン・1(CA’10
0μf/l、コーンステイブリカー10d/l、D−α
−アミノ−記数0.25%)10−を゛、 24φ大型
臥験官に分圧・滅菌後(滅菌後pl(7,0)、前培養
液を0.1−植菌し、無園的にエタノールを0、3−加
え、30℃にて7日間振盪培養を行なう。エタノールは
消費にともない飽加するU (この時エタノールは3容
量船)越えないようにする。また全エタノール消費tは
6.5容tSであった。)培養7日目にL−イソロイシ
ンが培養液1/当り1.1?蓄槓された。
Example 12 Preculture was carried out under the same conditions as those for Sei mushio+41. Next, the main culture medium (urea 0.4%, ammonium sulfate -1.4%,
K2HPO40.05%, K2HPO40.05chi, M
g S04 ・7 HxO0,05To, CaC1z
#2 Hzo 2 PPm%FeSO4・7H202
ppmSMn5O+ ・4~6 HsO2ppm%Zn
SO4” 71 (202ppm, N&C12ppm,
Biotin 200 μfl/l, Thiamin 1 (CA'10
0 μf/l, corn stable liquor 10 d/l, D-α
-Amino-number 0.25%) 10-, after partial pressure sterilization in a 24φ large reclining tester (after sterilization pl (7,0), inoculate 0.1- Add 0,3 - ethanol and culture with shaking at 30°C for 7 days. Ethanol becomes saturated as it is consumed, so do not exceed U (3 volumes of ethanol at this time). Also, the total ethanol consumption T (was 6.5 volumes tS.) On the 7th day of culture, L-isoleucine was 1.1% per culture solution. It was hoarded.

実施例1と同様の操作によりL−イソロイシンの結晶を
析出させたところ、培養液11当り0.659であった
When L-isoleucine crystals were precipitated by the same operation as in Example 1, the amount was 0.659 per 11 culture solutions.

なお同条件にて親株(ivfJ−233)を培養したと
ころ培養W1.11当、り 0.3 rのL−イソロイ
シンが生成蓄積された。
When the parent strain (ivfJ-233) was cultured under the same conditions, 0.3 r of L-isoleucine was produced and accumulated per culture W1.11.

Claims (1)

【特許請求の範囲】[Claims] 1 ブレビバクテリウム属に属し、D−α−アミノ酪酸
デアミナーゼ活性が増大したエタノール資化性微生物を
、エタノールを主炭素源とし且DL−α−アミノ酪酸も
しくはD−α−アミノ酪酸を含む培地に、好気的に培養
して培養液中にL−イソロイシンを生産蓄積せしめ、こ
の培養液よりL−イソロイシンを採取することを特徴と
する発酵法によるL−イソロイシンの製造法。
1. Ethanol-utilizing microorganisms belonging to the genus Brevibacterium and having increased D-α-aminobutyric acid deaminase activity were grown in a medium containing ethanol as the main carbon source and containing DL-α-aminobutyric acid or D-α-aminobutyric acid. A method for producing L-isoleucine by a fermentation method, which comprises culturing aerobically to produce and accumulate L-isoleucine in a culture solution, and collecting L-isoleucine from the culture solution.
JP1750185A 1985-01-31 1985-01-31 Production of l-isoleucine Pending JPS61177993A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1750185A JPS61177993A (en) 1985-01-31 1985-01-31 Production of l-isoleucine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1750185A JPS61177993A (en) 1985-01-31 1985-01-31 Production of l-isoleucine

Publications (1)

Publication Number Publication Date
JPS61177993A true JPS61177993A (en) 1986-08-09

Family

ID=11945736

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1750185A Pending JPS61177993A (en) 1985-01-31 1985-01-31 Production of l-isoleucine

Country Status (1)

Country Link
JP (1) JPS61177993A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1318387C (en) * 2005-12-12 2007-05-30 无锡晶海氨基酸有限公司 Cleaning production process of extracting L-isoleucine from fermented liquor using ion-exchange
JP2008017804A (en) * 2006-07-14 2008-01-31 Kanei Matsui Shokai:Kk Sand holding anchor
CN102040531A (en) * 2010-11-23 2011-05-04 五洲明珠股份有限公司 Method for extracting L-isoleucine

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1318387C (en) * 2005-12-12 2007-05-30 无锡晶海氨基酸有限公司 Cleaning production process of extracting L-isoleucine from fermented liquor using ion-exchange
JP2008017804A (en) * 2006-07-14 2008-01-31 Kanei Matsui Shokai:Kk Sand holding anchor
CN102040531A (en) * 2010-11-23 2011-05-04 五洲明珠股份有限公司 Method for extracting L-isoleucine

Similar Documents

Publication Publication Date Title
JP3046332B2 (en) Production of amino acids by fermentation
JPS6274293A (en) Production of l-isoleucine
JPS6115696A (en) Preparation of l-isoleucine by fermentation method
US5188947A (en) Process and microorganism for producing l-ornithine by corynebacterium, brevibacterium, or athrobacter
JPS61177993A (en) Production of l-isoleucine
JPH02219582A (en) Preparation of l-threonine by fermentation method
JPH01296994A (en) Production of l-glutamic acid
US2947666A (en) Amino acids and process
JPS61119194A (en) Production of l-ornithine through fermentation process
JP3100763B2 (en) Method for producing L-arginine by fermentation
JPS63160592A (en) Production of l-valine
DE2358496A1 (en) PROCESS FOR PRODUCING L-SERINE
JP2995816B2 (en) Production method of L-lysine by fermentation method
JPS6251998A (en) Production of l-isoleucine
AT208320B (en) Process for the production of 1-glutamic acid
JPH0314436B2 (en)
JPS62265988A (en) Production of l-arginine by fermentation
JPS5928398B2 (en) Method for producing L-isoleucine
AT208319B (en) Process for the production of 1-glutamic acid
JPS6078593A (en) Preparation of adenosine by fermentation
JPH02295491A (en) Preparation of l-isoleucine
JPS61260891A (en) Production of l-threonine by fermentation method
JPS61199794A (en) Production of l-truptophane through fermentation process
JPS5955194A (en) Preparation of l-leucine and microorganism therefor
JPH01112992A (en) Production of l-isoleucine